News

Strategic IP expansion protects federated learning technology driving pharma partnerships, biosecurity initiatives, and ...
Clinical trials remain the cornerstone of evidence-based medicine, yet they are frequently protracted and costly. More often ...
Traditionally, drug discovery relied heavily on trial and error, with long timelines and high costs. The introduction of ...
With Nvidia Blackwell architecture, the health system says it can further develop foundation models that tailor treatments to ...
A New Era of Research with Health Studio Clinical trials are the backbone of medical advancement but they’ve historically ...
We spoke with endocrinologists to explore the potential of artificial intelligence in the management of chronic disease, including diabetes, obesity, and PCOS.
NetraMark Holdings Inc. (the 'Company” or 'NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company transforming clinical trials and Pentara Corporation ( ...
As AI technology increasingly amalgamates into the medical arena, health system leaders are stepping up to help steer the path forward. Women comprise only 30% of those working in AI today, and ...
AI correctly identified 32.6% of the interval breast cancers. Features of AI-detected cancers included larger size at ...
AI is increasingly being adopted by sponsors for various applications in clinical trials, including optimising trial design, identifying suitable patients and analysing data, among other uses ...
Artificial Intelligence-based Clinical Trial Solutions for Patient Matching Market Research Report 2025 - ResearchAndMarkets.com February 04, 2025 01:06 PM Eastern Standard Time ...
Insight Health has raised $4.6 million to alleviate the routine aspects of care across the patient journey—using AI clinical ...